Blood and Blood Components Market By Product (Whole Blood, Blood Components, Blood Derivatives) , By Application (Anemia, Trauma & Surgery, Cancer Treatment, Bleeding Disorders) By End User (Hospitals, Ambulatory Surgical Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Blood and Blood Components Market Expected to Garner $18.6 Billion by 2033, Growing at a CAGR of 3.8%
Abstract: The global blood and blood components market is expected to grow primarily due to the rising global incidence of chronic diseases and advancements in blood processing & testing technologies. The North America region is predicted to witness profitable growth by 2033.
As per the report published by Research Dive, the global blood and blood components market was valued at $12.9 billion in 2023 and is expected to register a revenue of $18.6 billion by 2033 at a CAGR of 3.8% during the forecast period 2024-2033.
Dynamics of the MarketThe increasing prevalence of accidents and surgical procedures, growing incidence of chronic diseases, and the rising demand for blood transfusions are expected to make the blood and blood components market a highly profitable one in the forecast period. Besides, the use of blood and blood components is expanding across various medical procedures, including organ transplants, cancer treatments, and aesthetic procedures, thereby driving market growth.
However, according to market analysts, the high compliance cost, stringent regulations, and diverse regulatory frameworks across different regions might restrain the growth of the market.
Advancements in blood processing, storage, and testing technologies enhance the efficiency and safety of blood products, which is predicted to offer numerous growth opportunities for the market in the forecast period. Moreover, ongoing R&D efforts aimed at improving blood technologies present significant opportunities for blood and blood components market growth, enabling healthcare providers to meet increasing demand confidently.
Key Players of the MarketThe major players of the blood and blood components market include Becton, Dickinson & Co., Bio-Rad Laboratories, Inc., Kidde-Fenwal Inc., Cerus Corporation, Beckman Coulter, Inc., Immucor, bioMérieux SA, Abbott, and Octapharma AG.
What the Report CoversIn addition to the details highlighted in this description, the comprehensive final report delves into essential market aspects. These encompass a market overview, SWOT analysis, market dynamics, Porter’s five forces analysis, segmentation (key trends, regional analysis, and forecast analysis), and company profiles (including company overview, product portfolio, operating segments, strategic initiatives, and financial performance).
Key Market SegmentsBy ProductWhole Blood
Blood Components
Blood Derivatives
By ApplicationAnemia
Trauma Surgery
Cancer Treatment
Bleeding Disorders
By End UserHospitals
Ambulatory Surgical Centers
Others
By RegionNorth America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Russia
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Thailand
Malaysia
Indonesia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
UAE
Argentina
Rest of LAMEA
Key Market PlayersBecton
Dickinson & Co.
Kidde-Fenwal Inc.
Bio-Rad Laboratories, Inc.
Cerus Corporation
Immucor
Beckman Coulter, Inc.
BioMerieux SA
Octapharma AG
Abbott